Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Hepatitis C, Chronic D019698 12 associated lipids
Coronary Stenosis D023921 6 associated lipids
Aggressive Periodontitis D010520 8 associated lipids
Renal Insufficiency, Chronic D051436 9 associated lipids
Arteriosclerosis Obliterans D001162 8 associated lipids
Encephalitis D004660 15 associated lipids
Thyroiditis, Autoimmune D013967 9 associated lipids
Cholestasis, Intrahepatic D002780 4 associated lipids
Contracture D003286 3 associated lipids
Stomatitis D013280 14 associated lipids
Weight Loss D015431 56 associated lipids
Endotoxemia D019446 27 associated lipids
Blister D001768 16 associated lipids
Memory Disorders D008569 33 associated lipids
Acute Lung Injury D055371 33 associated lipids
Neurodegenerative Diseases D019636 32 associated lipids
Granulomatosis with Polyangiitis D014890 5 associated lipids
Lupus Nephritis D008181 8 associated lipids
Pancreatitis, Acute Necrotizing D019283 18 associated lipids
Ileal Diseases D007077 3 associated lipids
Ventricular Remodeling D020257 28 associated lipids
Gliosis D005911 6 associated lipids
Neuralgia D009437 28 associated lipids
Pneumonia, Bacterial D018410 16 associated lipids
Mammary Neoplasms, Animal D015674 27 associated lipids
Amnesia D000647 12 associated lipids
Tachycardia, Ventricular D017180 9 associated lipids
Hypoxia-Ischemia, Brain D020925 22 associated lipids
Sneezing D012912 6 associated lipids
Endometrial Neoplasms D016889 30 associated lipids
Malaria, Falciparum D016778 22 associated lipids
Liver Failure D017093 5 associated lipids
Hepatitis, Alcoholic D006519 5 associated lipids
Helicobacter Infections D016481 21 associated lipids
Gastroesophageal Reflux D005764 10 associated lipids
Mucositis D052016 7 associated lipids
Ileitis D007079 2 associated lipids
Carcinoma, Embryonal D018236 8 associated lipids
Postoperative Hemorrhage D019106 7 associated lipids
Neoplastic Cells, Circulating D009360 5 associated lipids
Corneal Neovascularization D016510 8 associated lipids
Xeroderma Pigmentosum D014983 6 associated lipids
Shock, Cardiogenic D012770 5 associated lipids
Hypertrophy, Right Ventricular D017380 4 associated lipids
Strongylida Infections D017206 5 associated lipids
Enterocolitis, Necrotizing D020345 3 associated lipids
Milk Hypersensitivity D016269 4 associated lipids
Hematoma, Subdural D006408 3 associated lipids
Venous Thrombosis D020246 11 associated lipids
Blood Loss, Surgical D016063 6 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Mollinedo F et al. Selective induction of apoptosis in cancer cells by the ether lipid ET-18-OCH3 (Edelfosine): molecular structure requirements, cellular uptake, and protection by Bcl-2 and Bcl-X(L). 1997 Cancer Res. pmid:9102220
Denizot Y et al. Presence and metabolism of lyso platelet-activating factor in human bone marrow. 1997 J Lipid Mediat Cell Signal pmid:9101422
Kudolo GB et al. Chronic hyperinsulinemia inhibits platelet-activating factor (PAF) biosynthesis in the rat kidney. 1997 J Lipid Mediat Cell Signal pmid:9101420
Rocha FA et al. PAF modulates eicosanoids and TNF release in immune-complex arthritis in rats. 1997 J Lipid Mediat Cell Signal pmid:9101418
Matsubara T et al. Platelet-activating factor (PAF) and PAF acetylhydrolase activity in rat uterus and placenta during the late stages of pregnancy. 1997 Biol. Reprod. pmid:9096869
Byrum RS et al. Role of the 5-lipoxygenase-activating protein (FLAP) in murine acute inflammatory responses. 1997 J. Exp. Med. pmid:9091580
Yatsu T et al. Renal effect of YM435, a new dopamine D1 receptor agonist, in anesthetized dogs. 1997 Eur. J. Pharmacol. pmid:9088869
Lin CC and Lin CY Bronchoconstriction and eosinophil recruitment in guinea pig lungs after platelet activating factor administration. 1997 J Asthma pmid:9088302
Kurose I et al. Oxidative stress during platelet-activating factor-induced microvascular dysfunction. 1996 Microcirculation pmid:9086452
Kume K et al. [Study of platelet activating factor by using mouse ontogenic technology]. 1996 Nihon Rinsho Meneki Gakkai Kaishi pmid:9081720
Mori TA et al. Interactions between dietary fat, fish, and fish oils and their effects on platelet function in men at risk of cardiovascular disease. 1997 Arterioscler. Thromb. Vasc. Biol. pmid:9081682
Mineshita M et al. Whole-blood incubation method to study neutrophil cytoskeletal dynamics. 1997 J. Immunol. Methods pmid:9075772
Tamura T et al. Effects of platelet-activating factor on left ventricular performance in dogs. 1997 Jpn. Circ. J. pmid:9070974
Gomez R et al. Pathogenesis of preterm labor and preterm premature rupture of membranes associated with intraamniotic infection. 1997 Infect. Dis. Clin. North Am. pmid:9067790
Kagoshima M et al. Effects of Y-24180, a long-acting and potent antagonist to platelet-activating factor, on immediate asthmatic response in guinea pigs. 1997 Pharmacology pmid:9065955
Wang H et al. Regulation of platelet-activating factor receptor gene expression in vivo by endotoxin, platelet-activating factor and endogenous tumour necrosis factor. 1997 Biochem. J. pmid:9065783
Bauldry SA and Wooten RE Induction of cytosolic phospholipase A2 activity by phosphatidic acid and diglycerides in permeabilized human neutrophils: interrelationship between phospholipases D and A2. 1997 Biochem. J. pmid:9065750
Odawara M et al. Ginkgo biloba. 1997 Neurology pmid:9065574
Ishii I et al. Alanine exchanges of polar amino acids in the transmembrane domains of a platelet-activating factor receptor generate both constitutively active and inactive mutants. 1997 J. Biol. Chem. pmid:9065450
Becker BF et al. [Interaction of adenosine with leukocytes and thrombocytes]. 1996 Z Kardiol pmid:9064961
Nick JA et al. Common and distinct intracellular signaling pathways in human neutrophils utilized by platelet activating factor and FMLP. 1997 J. Clin. Invest. pmid:9062356
Ohkuni H et al. Purification and partial characterization of a novel human platelet aggregation factor in the extracellular products of Streptococcus mitis, strain Nm-65. 1997 FEMS Immunol. Med. Microbiol. pmid:9061358
Lee YP et al. Analysis of human lecithin-cholesterol acyltransferase activity by carboxyl-terminal truncation. 1997 Biochim. Biophys. Acta pmid:9059515
Bussolino F et al. Role of soluble mediators in angiogenesis. 1996 Eur. J. Cancer pmid:9059328
Yousefi S et al. Platelet-activating factor and the production of human interferon-gamma. 1997 J. Interferon Cytokine Res. pmid:9058317
Abu-Zidan FM et al. Role of platelet-activating factor on cardiovascular dysfunction in postischemic shock in pigs. 1997 Eur Surg Res pmid:9058081
Anderson MR and Blumer JL Advances in the therapy for sepsis in children. 1997 Pediatr. Clin. North Am. pmid:9057790
Clinical studies of IL-11, new platelet growth factor, presented. 1997 Oncology (Williston Park, N.Y.) pmid:9057177
Collins LC and Roberts AM Effects of platelet-activating factor on arteriolar and venular tone in rat trachea. 1997 Microvasc. Res. pmid:9056476
Forde RC and Fitzgerald DJ Reactive oxygen species and platelet activation in reperfusion injury. 1997 Circulation pmid:9054729
Rodriguez-Barbero A et al. Involvement of platelet-activating factor in gentamicin nephrotoxicity in rats. 1997 Jan-Feb Exp. Nephrol. pmid:9052848
Gruska S et al. Prevalence of increased intracellular signal transduction in immortalized lymphoblasts from patients with essential hypertension and normotensive subjects. 1997 J. Hypertens. pmid:9050967
Lin CH et al. The effect of the selective PAF antagonist CIS-19 on PAF- and antigen-induced bronchoconstriction, microvascular leakage and bronchial hyperreactivity in guinea-pigs. 1997 Naunyn Schmiedebergs Arch. Pharmacol. pmid:9050014
Saitoh C et al. Effect of YM934, a KATP channel opener, on airway hyperresponsiveness induced by platelet activating factor in guinea-pigs. 1997 Naunyn Schmiedebergs Arch. Pharmacol. pmid:9050013
Chang TW Improvement of survival from hemorrhagic shock by enterectomy in rats: finding to implicate the role of the gut for irreversibility of hemorrhagic shock. 1997 J Trauma pmid:9042872
Bonaccorsi L et al. Protein tyrosine kinase, mitogen-activated protein kinase and protein kinase C are involved in the mitogenic signaling of platelet-activating factor (PAF) in HEC-1A cells. 1997 Biochim. Biophys. Acta pmid:9042336
Dohi T et al. Stimulation of platelet-activating factor synthesis by neurotransmitters in salivary glands. 1997 J. Dent. Res. pmid:9042079
Feuerstein G et al. Platelet-activating factor and cardiac diseases: therapeutic potential for PAF inhibitors. 1997 J Lipid Mediat Cell Signal pmid:9041476
Izzo AA and Benveniste J Presence of paf-acether in human blood after thin-layer chromatography, but not after high-performance liquid chromatography purification. 1996 J Pharmacol Toxicol Methods pmid:9040113
Brzustowicz LM et al. Linkage analysis using platelet-activating factor Ca2+ response in transformed lymphoblasts. 1997 Hypertension pmid:9039096
Rainger GE et al. Endothelial-borne platelet-activating factor and interleukin-8 rapidly immobilize rolling neutrophils. 1997 Am. J. Physiol. pmid:9038929
Barden A et al. Neutrophil CD11B expression and neutrophil activation in pre-eclampsia. 1997 Clin. Sci. pmid:9038589
Le Gouill C et al. Role of the Cys90, Cys95 and Cys173 residues in the structure and function of the human platelet-activating factor receptor. 1997 FEBS Lett. pmid:9037196
Morozova NG et al. [Synthesis of cationic alkylglucosides]. 1996 Oct-Nov Bioorg. Khim. pmid:9036840
Massicot F et al. Preventive effects of two PAF-antagonists, PMS 536 and PMS 549, on cyclosporin-induced LLC-PK1 oxidative injury. 1997 J Lipid Mediat Cell Signal pmid:9034965
Heymans F et al. Design and modeling of new platelet-activating factor antagonists. 3. Relative importance of hydrophobicity and electronic distribution in piperazinic series. 1997 J Lipid Mediat Cell Signal pmid:9034962
Tavet F et al. Design and modeling of new platelet-activating factor antagonists. 2. Synthesis and biological activity of 1,4-bis-(3',4',5'-trimethoxybenzoyl)-2-alkyl and 2-alkyloxymethylpiperazines. 1997 J Lipid Mediat Cell Signal pmid:9034961
Binisti C et al. Structure-activity relationships in platelet activating factor. 9. From PAF-antagonism to PLA2 inhibition. 1997 J Lipid Mediat Cell Signal pmid:9034960
Herbert JM et al. Effect of SR 27417, a novel PAF antagonist on antigen-induced hypotension in the rat. 1997 J Lipid Mediat Cell Signal pmid:9034959
Yoshikawa T et al. Role of superoxide and nitric oxide in platelet-activating factor-induced acute lung injury, hypotension, and mortality in rats. 1997 Crit. Care Med. pmid:9034266
Herbertson MJ et al. Platelet-activating factor antagonism improves ventricular contractility in endotoxemia. 1997 Crit. Care Med. pmid:9034254
Hotter G et al. Free radical enhancement promotes leucocyte recruitment through a PAF and LTB4 dependent mechanism. 1997 Free Radic. Biol. Med. pmid:9034233
Koenderman L Priming of circulating human eosinophils following late response to allergen challenge. 1997 Eur. Respir. J. pmid:9032524
Karpouza AP and Vakirtzi-Lemonias C The platelet-activating factor acetylhydrolase of mouse platelets. 1997 Biochim. Biophys. Acta pmid:9030208
Comminges C et al. Studies on ether-phospholipids of vascular smooth muscle cells. Identification of a rapid Ca(2+)-dependent hydrolysis of alkyl-phosphatidylethanolamine promoted by endothelin-l. 1997 Biochim. Biophys. Acta pmid:9030203
Packham MA et al. Exogenous diacylglycerols synergize with PAF with human platelets, but inhibit PAF-induced responses of rabbit platelets. 1996 J Lipid Mediat Cell Signal pmid:9029375
Bleivik B et al. Protein kinase C inhibitors and PAF stimulate phosphatidylserine synthesis in human leucocytes. 1996 J Lipid Mediat Cell Signal pmid:9029372
Denizot Y et al. PAF and haematopoiesis: IX. Platelet-activating factor increases DNA synthesis in human bone marrow cells. 1996 J Lipid Mediat Cell Signal pmid:9029369
He J et al. Micellar electrokinetic capillary chromatographic analysis of platelet activating factor in human blood by indirect ultraviolet detection. 1996 Ann. Ist. Super. Sanita pmid:9028060
Vlasova II et al. [Effect of a micellar preparation of polyunsaturated phosphatidylcholine on platelet aggregation in vitro]. 1996 Biull Eksp Biol Med pmid:9026131
Riera M et al. Neutrophils accentuate renal cold ischemia-reperfusion injury. Dose-dependent protective effect of a platelet-activating factor receptor antagonist. 1997 J. Pharmacol. Exp. Ther. pmid:9023292
Lee DR et al. Induction of acrosome reaction in human spermatozoa accelerates the time of pronucleus formation of hamster oocytes after intracytoplasmic sperm injection. 1997 Fertil. Steril. pmid:9022609
Fukuda AI and Breuel KF Effect of platelet activating factor on embryonic development and implantation in the mouse. 1996 Hum. Reprod. pmid:9021383
Bazan NG et al. Bioactive lipids in excitatory neurotransmission and neuronal plasticity. 1997 Neurochem. Int. pmid:9017670
Ohmori T et al. In vitro hypoxia of cortical and hippocampal CA1 neurons: glutamate, nitric oxide, and platelet activating factor participate in the mechanism of selective neural death in CA1 neurons. 1996 Brain Res. pmid:9017237
Carlson SA et al. Lack of constitutive activation or inactivation of the platelet-activating factor receptor by glutamate substitution of alanine 230. 1996 Recept Signal Transduct pmid:9015866
Maclennan KM et al. Platelet-activating factor in the CNS. 1996 Prog. Neurobiol. pmid:9015828
Chakrabarti R et al. Alteration of platelet-activating factor-induced signal transduction in macrophages by n-3 fatty acids. 1997 Cell. Immunol. pmid:9015191
Camussi G et al. Angiogenesis induced in vivo by hepatocyte growth factor is mediated by platelet-activating factor synthesis from macrophages. 1997 J. Immunol. pmid:9013973
Ishii S et al. Bronchial hyperreactivity, increased endotoxin lethality and melanocytic tumorigenesis in transgenic mice overexpressing platelet-activating factor receptor. 1997 EMBO J. pmid:9009274
Ohyama T et al. Sensitive densitometry for the determination of platelet-activating factor and other phospholipids in human tears. 1996 Analyst pmid:9008409
Souza-Fiho MV et al. Involvement of nitric oxide in the pathogenesis of cyclophosphamide-induced hemorrhagic cystitis. 1997 Am. J. Pathol. pmid:9006340
Vavilova GL et al. [The role of the thrombocyte-activating factor in inhibiting Na+,K(+)-ATPase in different tissues after ischemia and reperfusion of the small intestine]. 1996 Mar-Apr Ukr. Biokhim. Zh. pmid:9005660
O'Neill C Evidence for the requirement of autocrine growth factors for development of mouse preimplantation embryos in vitro. 1997 Biol. Reprod. pmid:9002654
Dagenais P et al. Augmented expression of platelet-activating factor receptor gene by TNF-alpha through transcriptional activation in human monocytes. 1997 J. Leukoc. Biol. pmid:9000543
Sugatani J et al. High-density lipoprotein inhibits the synthesis of platelet-activating factor in human vascular endothelial cells. 1996 J Lipid Mediat Cell Signal pmid:8998599
Merlos M et al. Rupatadine, a new potent, orally active dual antagonist of histamine and platelet-activating factor (PAF). 1997 J. Pharmacol. Exp. Ther. pmid:8996188
Misra UK et al. Up-regulation of the alpha2-macroglobulin signaling receptor on rheumatoid synovial fibroblasts. 1997 J. Biol. Chem. pmid:8995289
Tuomanen EI Molecular and cellular mechanisms of pneumococcal meningitis. 1996 Ann. N. Y. Acad. Sci. pmid:8993350
Laniyonu AA et al. Endotoxin-induced microvascular leakage is prevented by a PAF antagonist and NO synthase inhibitor. 1997 Shock pmid:8989836
Ohtani N and Asano G [Purification and partial characterization of a novel human platelet aggregation factor in the extracellular products of Streptococcus mitis, strain Nm-65]. 1996 Nippon Ika Daigaku Zasshi pmid:8987363
Ferreira MG and Fonteles MC Different classes of PAF-antagonists block norepinephrine-induced vascular escape and tachyphylaxis in the isolated rabbit kidney. 1996 Res. Commun. Mol. Pathol. Pharmacol. pmid:8987112
de Boissieu D et al. Effect of BN 50727 on pathological findings and tissue platelet activating factor levels during ileal ischemia in newborn piglets. 1996 J. Pediatr. Surg. pmid:8986985
Michibayashi T [Vascular responsiveness of platelet activating factor--with special reference to its action in the presence of platelets]. 1996 J Smooth Muscle Res pmid:8985919
Monteseirín J et al. Formation of lipids, peptides and cytokines. 1996 Sep-Oct Allergol Immunopathol (Madr) pmid:8985477
Ho YS et al. Brain acetylhydrolase that inactivates platelet-activating factor is a G-protein-like trimer. 1997 Nature pmid:8985254
Dentener MA et al. Bactericidal/permeability-increasing protein release in whole blood ex vivo: strong induction by lipopolysaccharide and tumor necrosis factor-alpha. 1997 J. Infect. Dis. pmid:8985203
Williams FM Neutrophils and myocardial reperfusion injury. 1996 Pharmacol. Ther. pmid:8981567
Anderson R et al. Membrane-stabilizing, anti-inflammatory interactions of macrolides with human neutrophils. 1996 Inflammation pmid:8979156
Sugano M et al. Structure-activity relationships of phomactin derivatives as platelet activating factor antagonists. 1996 J. Med. Chem. pmid:8978857
Bkaily G et al. Modulation of cardiac cell Ca2+ currents by PAF. 1996 Blood Press Suppl pmid:8973773
Terada N et al. The effect of anti-VLA-4 monoclonal antibody on eosinophil accumulation and leukotriene production in nasal mucosa. 1996 Acta Otolaryngol. pmid:8973726
Tokumura A et al. Lipid peroxidation in low density lipoproteins from human plasma and egg yolk promotes accumulation of 1-acyl analogues of platelet-activating factor-like lipids. 1996 Lipids pmid:8972457
Liu L et al. Transmigration of human neutrophils across airway epithelial cell monolayers is preferentially in the physiologic basolateral-to-apical direction. 1996 Am. J. Respir. Cell Mol. Biol. pmid:8969272
West RR et al. ZG-1494 alpha, a novel platelet-activating factor acetyltransferase inhibitor from Penicillium rubrum, isolation, structure elucidation andbiological activity. 1996 J. Antibiot. pmid:8968388
Despotis GJ et al. Evaluation of a new point-of-care test that measures PAF-mediated acceleration of coagulation in cardiac surgical patients. 1996 Anesthesiology pmid:8968178
Sagara H et al. Theophylline at therapeutic concentration suppresses PAF-induced upregulation of Mac-1 on human eosinophils. 1996 Clin. Exp. Allergy pmid:8963871
Roudebush WE et al. Effect of platelet-activating factor (PAF) on preimplantation mouse B6D2F1/J embryo formation. 1996 Am. J. Reprod. Immunol. pmid:8962660
Minhas BS et al. Platelet activating factor and conception. 1996 Am. J. Reprod. Immunol. pmid:8962659
Izzo AA PAF and the digestive tract. A review. 1996 J. Pharm. Pharmacol. pmid:8961155